Identification of KRAP-expressing cells and the functional relevance of KRAP to the subcellular localization of IP3R in the stomach and kidney

International Journal of Molecular Medicine

Volumn 30, Issue 6, 2012, Pages 1287-1293

  Fujimoto, Takahiro ^a   Shirasawa, Senji ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Immunohistochemical staining; Inositol 1,4,5 trisphosphate receptor; Kidney; Protein protein interaction; RAS induced actin interacting protein; Stomach

Indexed keywords

INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; K RAS INDUCED ACTIN INTERACTING PROTEIN; K RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY PROXIMAL TUBULE; MUCOUS CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH CHIEF CELL;

ANIMALS; CHIEF CELLS, GASTRIC; GASTRIC MUCOSA; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; KIDNEY; KIDNEY TUBULES, PROXIMAL; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; MICROSCOPY, FLUORESCENCE; ORGAN SPECIFICITY; PROTEIN TRANSPORT;

EID: 84869384246     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1126     Document Type: Article

References (31)

1. Ross CA, Danoff SK, Schell MJ, Snyder SH and Ullrich A: Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues. Proc Natl Acad Sci USA 89: 4265-4269, 1992.
2. Sharp AH, McPherson PS, Dawson TM, Aoki C, Campbell KP and Snyder SH: Differential immunohistochemical localization of inositol 1,4,5-trisphosphate- and ryanodine-sensitive Ca2+release channels in rat brain. J Neurosci 13: 3051-3063, 1993. (Pubitemid 23199230)
3. Sugiyama T, Yamamoto-Hino M, Miyawaki A, Furuichi T, Mikoshiba K and Hasegawa M: Subtypes of inositol 1,4,5-trisphosphate receptor in human hematopoietic cell lines: dynamic aspects of their cell-type specific expression. FEBS Lett 349: 191-196, 1994.
4. Newton CL, Mignery GA and Südhof TC: Co-expression in vertebrate tissues and cell lines of multiple inositol 1,4,5-trisphosphate (InsP3) receptors with distinct affinities for InsP3. J Biol Chem 269: 28613-28619, 1994. (Pubitemid 24366693)
5. Wojcikiewicz RJ: Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types. J Biol Chem 270: 11678-11683, 1995.
6. Jayaraman T, Ondriasová E, Ondrias K, Harnick DJ and Marks AR: The inositol 1,4,5-trisphosphate receptor is essential for T-cell receptor signaling. Proc Natl Acad Sci USA 92: 6007-6011, 1995.
7. Khan AA, Soloski MJ, Sharp AH, Schilling G, Sabatini DM, Li SH, Ross CA and Snyder SH: Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor. Science 273: 503-507, 1996. (Pubitemid 26286452)
8. Sugawara H, Kurosaki M, Takata M and Kurosaki T: Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor. EMBO J 16: 3078-3088, 1997. (Pubitemid 27234947)
9. Scharenberg AM, Humphries LA and Rawlings DJ: Calcium signalling and cell-fate choice in B cells. Nat Rev Immunol 7: 778-789, 2007. (Pubitemid 47480308)
10. deSouza N, Cui J, Dura M, McDonald TV and Marks AR: A function for tyrosine phosphorylation of type 1 inositol 1,4,5-trisphosphate receptor in lymphocyte activation. J Cell Biol 179: 923-934, 2007. (Pubitemid 350223489)
11. Patterson RL, Boehning D and Snyder SH: Inositol 1,4,5-trisphosphate receptors as signal integrators. Annu Rev Biochem 73: 437-465, 2004. (Pubitemid 39050376)
12. Bezprozvanny I: The inositol 1,4,5-trisphosphate receptors. Cell Calcium 38: 261-272, 2005.
13. 2+ release channels. Physiol Rev 87: 593-658, 2007.
14. 2+ channel: from discovery to new signaling concepts. J Neurochem 102: 1426-1446, 2007.
15. Zhang S, Fritz N, Ibarra C and Uhlén P: Inositol 1,4,5-trisphosphate receptor subtype-specific regulation of calcium oscillations. Neurochem Res 36: 1175-1185, 2011.
16. Inokuchi J, Komiya M, Baba I, Naito S, Sasazuki T and Shirasawa S: Deregulated expression of KRAP, a novel gene encoding actin-interacting protein, in human colon cancer cells. J Hum Genet 49: 46-52, 2004. (Pubitemid 38186125)
17. Fujimoto T, Miyasaka K, Koyanagi M, Tsunoda T, Baba I, Doi K, Ohta M, et al: Altered energy homeostasis and resistance to diet-induced obesity in KRAP-deficient mice. PLoS One 4: e4240, 2009.
18. Miyasaka K, Fujimoto T, Kawanami T, Takiguchi S, Jimi A, Funakoshi A and Shirasawa S: Pancreatic hypertrophy in Ki-ras-induced actin-interacting protein gene knockout mice. Pancreas 40: 79-83, 2011.
19. Fujimoto T, Koyanagi M, Baba I, Nakabayashi K, Kato N, Sasazuki T and Shirasawa S: Analysis of KRAP expression and localization, and genes regulated by KRAP in a human colon cancer cell line. J Hum Genet 52: 978-984, 2007. (Pubitemid 350164615)
20. Fujimoto T, Machida T, Tanaka Y, Tsunoda T, Doi K, Ota T, Okamura T, et al: KRAS-induced actin-interacting protein is required for the proper localization of inositol 1,4,5-trisphosphate receptor in the epithelial cells. Biochem Biophys Res Commun 407: 438-443, 2011.
21. Fujimoto T, Machida T, Tsunoda T, Doi K, Ota T, Kuroki M and Shirasawa S: Determination of the critical region of KRAS-induced actin-interacting protein for the interaction with inositol 1,4,5-trisphosphate receptor. Biochem Biophys Res Commun 408: 282-286, 2011.
22. Mills JC, Andersson N, Stappenbeck TS, Chen CC and Gordon JI: Molecular characterization of mouse gastric zymogenic cells. J Biol Chem 278: 46138-46145, 2003. (Pubitemid 37432764)
23. Zhu L, Hatakeyama J, Zhang B, Makdisi J, Ender C and Forte JG: Novel insights of the gastric gland organization revealed by chief cell specific expression of moesin. Am J Physiol Gastrointest Liver Physiol 296: G185-G195, 2009.
24. Schubert ML: Gastric exocrine and endocrine secretion. Curr Opin Gastroenterol 25: 529-536, 2009.
25. Futatsugi A, Nakamura T, Yamada MK, Ebisui E, Nakamura K, Uchida K, Kitaguchi T, et al: IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science 309: 2232-2234, 2005. (Pubitemid 41396076)
26. Wright SH and Dantzler WH: Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 84: 987-1049, 2004. (Pubitemid 38823772)
27. Alrefai WA and Gill RK: Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res 24: 1803-1823, 2007. (Pubitemid 47389235)
28. Husain S and Thrower E: Molecular and cellular regulation of pancreatic acinar cell function. Curr Opin Gastroenterol 25: 466-471, 2009.
29. Anzai N, Jutabha P, Kanai Y and Endou H: Integrated physiology of proximal tubular organic anion transport. Curr Opin Nephrol Hypertens 14: 472-479, 2005. (Pubitemid 41152711)
30. Hernando N, Wagner CA, Gisler SM, Biber J and Murer H: PDZ proteins and proximal ion transport. Curr Opin Nephrol Hypertens 13: 569-574, 2004. (Pubitemid 39150085)
31. Brône B and Eggermont J: PDZ proteins retain and regulate membrane transporters in polarized epithelial cell membranes. Am J Physiol Cell Physiol 288: C20-C29, 2005. (Pubitemid 39658423)